Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/26/1991 | CA2084058A1 Recombinant 21 kd cocoa protein and precursor |
12/26/1991 | CA2045326A1 Non-a, non-b, hepatitis virus particles |
12/25/1991 | CN1057295A Process for isolation and expression of human ciliary neuronotrophic factor by recombinant dna technology |
12/25/1991 | CN1057294A Method for recombinant production of hirudins |
12/25/1991 | CN1057268A Crystalline interleukin-4 |
12/24/1991 | US5075424 Acidification of milk solution, ultrafiltration |
12/24/1991 | US5075423 Purification of protein a by affinity chromatography followed by anion exchange |
12/24/1991 | US5075288 Sleep inducer |
12/24/1991 | US5075236 Method of detecting kawasaki disease using anti-tumor necrosis antibody |
12/24/1991 | US5075228 Hydrib conposed of chlamydia and escherichia components |
12/24/1991 | US5075224 Prepro-LHRH C-terminal peptide DNA |
12/24/1991 | US5075222 Dna sequences |
12/24/1991 | US5075211 Complexing antibodies with oligopeptides, blood screening |
12/24/1991 | US5075108 Acylation of mephalan by an anhydride |
12/24/1991 | US5074982 Polymer bonded to silica containing material |
12/24/1991 | CA1293591C Peptide substrates for detecting virus-specified protease activity |
12/23/1991 | CA2044908A1 In vivo targeting with bifuncitonal antibodies |
12/22/1991 | WO1991019799A1 Method for isolating mutant cells |
12/22/1991 | CA2085893A1 Method for isolating mutant cells |
12/22/1991 | CA2045071A1 Acellular anti-pertussis vaccines |
12/22/1991 | CA2044858A1 Method of treating bladder cancer cells |
12/22/1991 | CA2043992A1 Use of cytokine-containing aerosols and the cytokine-containing aerosols |
12/21/1991 | WO1991019818A1 Peptide library and screening systems |
12/21/1991 | WO1991019817A1 EXPRESSION VECTORS CONTAINING THE HIV nef GENE TO ENHANCE REPLICATION EFFICIENCY |
12/21/1991 | WO1991019798A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
12/21/1991 | CA2085880A1 Expression vectors containing the hiv nef gene to enhance replication efficiency |
12/21/1991 | CA2084659A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
12/21/1991 | CA2084411A1 Peptide library and screening systems |
12/21/1991 | CA2044985A1 Recombinant human osteocalcin |
12/19/1991 | WO1991019802A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris |
12/19/1991 | WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use |
12/19/1991 | DE4018988A1 New Borrelia burgdorferi proteins |
12/19/1991 | CA2085580A1 Bacteriocin from a strain of lactococcus lactis subsp. cremoris |
12/19/1991 | CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use |
12/19/1991 | CA2044717A1 Process for the separation of proteins, polypeptides or metals |
12/19/1991 | CA2038237A1 Amine enriched proteins |
12/18/1991 | EP0462065A2 New signal sequences |
12/18/1991 | EP0461863A1 Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus |
12/18/1991 | EP0461799A2 Bacillus thuringiensis isolate having anti-protozoan activity |
12/18/1991 | EP0461696A1 Crystalline polypeptides with corticotropic activity |
12/18/1991 | EP0461560A1 Recombinant human hepatocyte growth factor and method for production thereof |
12/18/1991 | EP0461330A1 Protease inhibitory fraction |
12/18/1991 | EP0461245A1 Radiolabeled proteins for diagnostic or therapeutic use |
12/18/1991 | EP0461193A1 Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits. |
12/18/1991 | EP0461178A1 Method for increasing the ability of maize to undergo androgenesis, and products produced therefrom |
12/18/1991 | EP0461177A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
12/18/1991 | EP0461159A1 Il-2 analogs containing n-linked glycosylation sites |
12/18/1991 | EP0461155A1 Improved methods for in vitro dna amplification and genomic cloning and mapping. |
12/18/1991 | EP0455741A4 Method for detecting inhibitors of tat protein |
12/18/1991 | EP0289572B1 Anti-arthritic use of interleukin-1 proteins |
12/18/1991 | EP0108128B1 (met-1,des-cys1,des-tyr2,des-cys3) human gamma interferon and a dna sequence encoding it |
12/17/1991 | US5073632 Insecticide |
12/17/1991 | US5073630 Culture product, phosphate anhydride |
12/17/1991 | US5073627 Animal growth regulator |
12/17/1991 | US5073626 Anhydrourokinase or urokinase mutated at position 356 from ser to gly |
12/17/1991 | US5073542 CPF peptide compositions and their use in inhibiting growth of target cells or a virus |
12/17/1991 | US5073541 Treatment of small cell lung cancer with somatostatin analogs |
12/17/1991 | US5073540 Composite binding site drugs |
12/17/1991 | US5073490 Immortalized eukaryotic mice cells producing somatotropins |
12/17/1991 | CA1293214C Process for the preparation of a factor v concentrate |
12/16/1991 | WO1991019814A2 Dna probes and primers for detection of b. burgdorferi using the polymerase chain reaction |
12/16/1991 | WO1991019805A1 A novel vector to produce biologically important peptides |
12/16/1991 | WO1991019742A1 Crystalline interleukin-4 |
12/16/1991 | CA2085377A1 Crystalline interleukin-4 |
12/16/1991 | CA2064582A1 Dna probes and primers for detection of b. burgdorferi using the polymerase chain reactions |
12/16/1991 | CA2044476A1 Signal sequences for targeting a protein into a plant vacuole |
12/15/1991 | WO1991019735A1 Libraries of modified peptides with protease resistance |
12/15/1991 | CA2085118A1 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
12/14/1991 | WO1991019745A1 Chimeric toxins with improved inter-domain geometry |
12/14/1991 | WO1991019494A1 Compositions for treating hiv-type 1 infection |
12/14/1991 | CA2085234A1 Compositions for treating hiv-type 1 infection |
12/14/1991 | CA2083487A1 Chimeric toxins with improved inter-domain geometry |
12/14/1991 | CA2043497A1 Crystalline polypeptides |
12/13/1991 | CA2044296A1 Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus |
12/13/1991 | CA2044191A1 Process for the purification of factor viii and factor viii obtained by said process |
12/12/1991 | WO1991019010A1 Method and probes for detection of alport syndrome |
12/12/1991 | WO1991019009A1 The ciliary neurotrophic factor receptor |
12/12/1991 | WO1991019007A1 Dna sequences involved in neuronal degeneration, multicellular organisms containing same and uses thereof |
12/12/1991 | WO1991019005A1 Dna for diagnosing pneumocystis carinii |
12/12/1991 | WO1991019001A1 Immunodiagnostic assay for rheumatoid arthritis |
12/12/1991 | WO1991018999A1 Yeast-derived epidermal growth factor/urogastrone-like products |
12/12/1991 | WO1991018998A1 An enzymatic process for the preparation of derivatives of growth hormone releasing factor and peptides useful as intermediates in the process |
12/12/1991 | WO1991018984A2 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
12/12/1991 | WO1991018983A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
12/12/1991 | WO1991018982A1 Type ii interleukin-1 receptors |
12/12/1991 | WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide |
12/12/1991 | WO1991018928A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use |
12/12/1991 | WO1991018926A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
12/12/1991 | WO1991018924A1 Mammalian adipogenic factors |
12/12/1991 | WO1991018923A1 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
12/12/1991 | WO1991018922A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
12/12/1991 | WO1991018913A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna |
12/12/1991 | WO1991018911A2 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
12/12/1991 | WO1991018625A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna |
12/12/1991 | WO1991018624A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna |
12/12/1991 | WO1991018620A1 Stimulation of bone marrow stromal and progenitor cells |
12/12/1991 | WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays |
12/12/1991 | WO1991018512A1 Method of inducing plant defense mechanisms |
12/12/1991 | WO1991016434A3 Bacillus thuringiensis cryif and cryix genes and proteins toxic to lepidopteran insects |
12/12/1991 | WO1991015582A3 Purified rap gaps, rap gap sequences, and uses thereof |